Long-term oestrogen therapy is associated with improved endothelium- dependent vasodilation in the forearm resistance circulation of biological males

Clinical and Experimental Pharmacology and Physiology

Volumn 27, Issue 1-2, 2000, Pages 25-33

  New, Gishel ^a   Duffy, Stephen J ^a   Harper, Richard W ^a   Meredith, Ian T ^a,b  

^a MONASH UNIVERSITY   (Australia)

^b MONASH MEDICAL CENTRE   (Australia)

Author keywords

Acetylcholine; Endothelium; Lipids; Microcirculation; Oestrogen

Indexed keywords

ACETYLCHOLINE; CHOLESTEROL; CONJUGATED ESTROGEN; ESTRADIOL VALERATE; ETHINYLESTRADIOL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PHENYLEPHRINE; TESTOSTERONE; VERAPAMIL;

ADULT; ARTERY DILATATION; ARTERY RESISTANCE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ESTROGEN THERAPY; FOREARM BLOOD FLOW; HUMAN; LONG TERM CARE; MALE; NORMAL HUMAN; RESISTANCE BLOOD VESSEL; TESTOSTERONE BLOOD LEVEL; TRANSSEXUALISM; TREATMENT OUTCOME; VASCULAR ENDOTHELIUM;

ACETYLCHOLINE; ADULT; ANALYSIS OF VARIANCE; ENDOTHELIUM, VASCULAR; ESTROGENS; FOREARM; HUMANS; LIPOPROTEINS; MALE; MIDDLE AGED; REGRESSION ANALYSIS; TESTOSTERONE; TRANSSEXUALISM; VASODILATION; VASODILATOR AGENTS;

EID: 0033981722     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1681.2000.03195.x     Document Type: Article

References (56)

1. New G, Timmins KL, Duffy SJ et al. Long-term estrogen therapy improves vascular function in male to female transsexuals. J. Am. Coll. Cardiol. 1947; 29: 1437-44.
2. McCrohon JA, Walters WA, Robinson JT et al. Arterial reactivity is enhanced in genetic males taking high dose estrogens. J. Am. Coll. Cardiol. 1997; 29: 1432-6.
3. Lieberman EH, Gerhard MD, Uehata A et al. Estrogen improves endothelium-dependent. flow-mediated vasodilation in postmenopausal women. Ann. Intern. Med. 1994; 121: 936-41.
4. McCrohon JA, Adams MR, McCredie RJ et al. Hormone replacement therapy is associated with improved arterial physiology in healthy post-menopausal women. Clin. Endocrinol. 1996; 45: 435-11.
5. Reis SE. Oestrogens attenuate abnormal coronary vasoreactivity in postmenopausal women. Ann. Med. 1994; 26: 387-8.
6. Sudhir K, Chou TM, Mullen WL et al. Mechanisms of estrogen-induced vasodilation: In vivo studies in canine coronary conductance and resistance arteries. J. Am. Coll. Cardiol. 1995; 26: 807-14.
7. Drexler H, Zeiher AM. Progression of coronary endothelial dysfunction in man and its potential clinical significance. Basic Res. Cardiol. 1991; 86: 223-32.
8. Meredith IT, Yeung AC, Weidinger FF et al. Role of impaired endothelium-dependent vasodilation in ischemic manifestations of coronary artery disease. Circulation 1993; 87 (Suppl. V): V56-66.
9. Rosano GM, Sarrel PM, Poole-Wilson PA, Collins P. Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease. Lancet 1993; 342: 133-6.
10. Kim YD, Chen B, Beauregard J et al. 17-beta-estradiol prevents dysfunction of canine coronary endothelium and myocardium and reperfusion arrhythmias after brief ischemia/reperfusion. Circulation 1996; 94: 2901-8.
11. Collins P, Rosano GM, Sarrel PM et al. 17-beta-estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease. Circulation 1995; 92: 24-30.
12. Blumenthal RS, Heldman AW, Brinker JA et al. Acute effects of conjugated estrogens on coronary blood flow response to acetylcholine in men. Am. J. Cardiol. 1997; 80: 1021-4.
13. Risk Factor Prevalence Study Management Committee. Risk Factor Prevalence Study: Survey No. 3. National Heart Foundation of Australia and Australian Institute of Health, Canberra. 1990.
14. Whitney RJ. The measurement of volume changes in human limbs. J. Physiol. 1953; 121: 1-27.
15. Duffy SJ, Tran BT, New G et al. Continuous release of vasodilator prostanoids contributes to the regulation of resting forearm blood flow in humans. Am. J. Physiol. 1998; 274: H1174-83.
16. Gilligan DM, Badar DM, Panza JA, Quyyumi AA, Cannon RO. Acute vascular effects of estrogen in postmenopausal women. Circulation 1994; 90: 786-91.
17. Amann FW, Bolli P, Kiowski W, Buhler FR. Enhanced alpha-adrenoreceptor-mediated vasoconstriction in essential hypertension. Hypertension 1981; 3 (Pt 2): I-119-23.
18. Linder L, Kiowski W, Buhler FR, Luscher TF. Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo. Blunted response in essential hypertension. Circulation 1990; 81: 1762-7.
19. Hulthen UL, Bolli P, Buhler FR. Vasodilatory effect of nicardipine and verapamil in the forearm of hypertensive as compared with normotensive man. Br. J. Clin. Pharmacol. 1985; 20 (Suppl. 1): S62-6.
20. Bolli P, Muller FB, Linder L et al. The vasodilator potency of atrial natriuretic peptide in man. Circulation 1987; 75: 221-8.
21. Williams JK, Kim YD, Adams MR, Chen MF, Myers AK, Ramwell PW. Effects of estrogen on cardiovascular responses of premenopausal monkeys. J. Pharmacol. Exp. Ther. 1994; 271: 671-6.
22. Smits P, Williams SB, Lipson DE, Banitt P, Rongen GA, Creager MA. Endothelial release of nitric oxide contributes to the vasodilator effect of adenosine in humans. Circulation 1995; 92: 2135-41.
23. Reis SE, Wu CW, Counihan PJ et al. Estrogen has an acute beneficial effect on coronary vasoreactivity in men. Circulation 1995; 92: I-249 (Abstract).
24. Reis SE, Bhoopalam V, Zell KA et al. Conjugated estrogens acutely abolish abnormal cold-induced coronary vasoconstriction in male cardiac allografts. Circulation 1998; 97: 23-5.
25. Reis SE, Gloth ST, Blumenthal RS et al. Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. Circulation 1994; 89: 52-60.
26. Gilligan DM, Quyyumi AA, Cannon RO. Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation 1994; 89: 2545-51.
27. Taddei S, Virdis A, Ghiadoni L et al. Menopause is associated with endothelial dysfunction in women. Hypertension 1996; 28: 576-82.
28. Volterrani M, Rosano G, Coats A, Beale C, Collins P. Estrogen acutely increases peripheral blood flow in postmenopausal women. Am. J. Med. 1995; 99: 119-22.
29. Pinto S, Virdis A, Ghiadoni L et al. Endogenous estrogen and acetylcholine-induced vasodilation in normotensive women. Hypertension 1997; 29: 268-73.
30. Gilligan DM, Badar DM, Panza JA, Quyyumi AA, Cannon RO. Effects of estrogen replacement therapy on peripheral vasomotor function in postmenopausal women. Am. J. Cardiol. 1995; 75: 264-8.
31. Mugge A, Riedel M, Barton M, Kuhn M, Lichtlen PR. Endothelium independent relaxation of human coronary arteries by 17 beta-oestradiol in vitro. Cardiovasc. Res. 1993; 27: 1939-42.
32. Chester AH, Jiang C, Borland JA, Yacoub MH, Collins P. Oestrogen relaxes human epicardial coronary arteries through non-endothelium-dependent mechanisms. Coron. Artery Dis. 1995; 6: 417-22.
33. Collins P, Beale CM, Rosano GM. Oestrogen as a calcium channel blocker. Eur. Heart J. 1996; 17: 27-31.
34. 2 in porcine coronary artery. Circulation 1995; 91: 2619-26.
35. 2+ currents in the A7r5 vascular smooth muscle cell line. Am. J. Physiol. 1994; 266: C975-80.
36. Miller VM, Gisclard V, Vanhoutte PM. Modulation of endothelium-dependent and vascular smooth muscle responses by oestrogens. Phlebology 1988; 3 (Suppl. 1): 63-9.
37. Colucci WS, Gimbrone Jr MA, McLaughlin MK, Halpern W, Alexander RW. Increased vascular catecholamine sensitivity and alpha-adrenergic receptor affinity in female and estrogen-treated male rats. Circ. Res. 1982; 50: 805-11.
38. Guetta V, Quyyumi AA, Prasad A, Panza JA, Waclawiw M, Cannon RO. The role of nitric oxide in coronary vascular effects of estrogen in postmenopausal women. Circulation 1997; 96: 2795-801.
39. 2 and NO in endothelial cells. Maturitas 1996; 25: 141-7.
40. Wingrove CS, Stevenson JC. 17-beta-oestradiol inhibits stimulated endothelin release in human vascular endothelial cells. Eur. J. Endocrinol. 1997; 137: 205-8.
41. Polderman KH, Stehouwer CD, van Kamp GJ, Dekker GA, Verbeugt FW, Gooren LJ. Influence of sex hormones on plasma endothelin levels. Ann. Intern. Med. 1993; 118: 429-32.
42. Barrett-Connor E, Bush TL. Estrogen and coronary heart disease in women. JAMA 1991; 265: 1861-7.
43. Damewood MD, Bellantoni JJ, Bachorik PS, Kimball Jr AW, Rock JA. Exogenous estrogen effect on lipid/lipoprotein cholesterol in transsexual males. J. Endocrinol. Invest. 1989; 12: 449-54.
44. Moorjani S, Dupont A, Labrie F et al. Changes in plasma lipoproteins during various androgen suppression therapies in men with prostatic carcinoma: Effects of orchiectomy, estrogen. and combination treatment with luteinizing hormone-releasing hormone agonist and flutamide. J. Clin. Endocrinol. Metab. 1988; 66: 314-22.
45. Haffner SM, Mykkanen L, Valdez RA, Katz MS. Relationship of sex hormones to lipids and lipoproteins in nondiabetic men. J. Clin. Endocrinol. Metab. 1993; 77: 1610-15.
46. 2 cholesterol levels in normal men. J. Clin. Endocrinol. Metab. 1994; 78: 855-61.
47. Egashira K, Hirooka Y, Kai H et al. Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia. Circulation 1994; 89: 2519-24.
48. Treasure CB, Klein JL, Weintraub WS et al. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N. Engl. J. Med. 1995; 332: 481-7.
49. Ohara Y, Peterson TE, Sayegh HS, Subramanian RR, Wilcox JN, Harrison DG. Dietary correction of hypercholesterolemia in the rabbit normalizes endothelial superoxide anion production. Circulation 1995; 92: 898-903,
50. Kuhn FE, Mohler ER, Satler LF, Reagan K, Lu DY, Rackley CE. Effects of high-density lipoprotein on acetylcholine-induced coronary vaso-reactivity. Am. J. Cardiol. 1991; 68: 1425-30.
51. LaRosa JC. Metabolic effects of estrogens and progestins. Fertil. Steril. 1994; 62 (Suppl. 2): S140-6.
52. Grady D, Rubin SM, Petitti DB et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann. Intern. Med. 1992; 117: 1016-37.
53. Grodstein F, Stampfer MJ, Manson JE et al. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N. Engl. J. Med. 1996; 335: 453-61.
54. Stampfer MJ, Willett WC, Colditz GA, Speizer FE, Hennekens CH. A prospective study of past use of oral contraceptive agents and risk of cardiovascular diseases. N. Engl. J. Med. 1988; 319: 1313-17.
55. Lundman P, Eriksson M, Schenck-Gustafsson K, Karpe F, Tornvall P. Transient triglyceridemia decreases vascular reactivity in young, healthy men without risk factors for coronary heart disease. Circulation 1997; 96: 3266-8.
56. Herman M, Robinson JTC, McCredie RJ, Adams MR, Boyer M, Celermajer DS. Androgen deprivation is associated with enhanced endothelium-dependent dilatation in adult men. Arterioscler. Thromb. Vasc. Biol. 1997; 17: 2004-9.